No recent analyst price targets found for CUBT.
Latest News for CUBT
Curative Biotechnology Advances Translational Ophthalmology Program Through PennVet Research Agreement
PennVet Study to Evaluate GMP-Grade Metformin Eye Drops in a Canine Model Supporting Human and Veterinary Development Pathways Palm Beach Gardens, FL, May 07, 2026 (GLOBE NEWSWIRE) -- Curative Biotechnology, Inc. (OTC: CUBT) ("Curative" or the "Company"), a development-stage biomedical company focused on novel therapies for degenerative eye diseases, today announced that it has entered into a Sponsored Research…
🧮 Earnings Move Analyzer
Insider Trading
No insider trades found for CUBT.
Senate Trading
No Senate trades found for CUBT.
U.S. House Trading
No House trades found for CUBT.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.